Abstract NTOC-106: FAK INHIBITION RE–SENSITIZES PLATINUM–RESISTANT SEROUS OVARIAN CANCER
L.M. Bean(Moores Cancer Center), David D. Schlaepfer(UC San Diego Health System), Xiao Lei Chen(Xiamen University), Kristen Anderson(Moores Cancer Center), Christine Jean(Centre National de la Recherche Scientifique), Dwayne G. Stupack(University of California San Diego), Vihren N. Kolev(Verastem (United States)), Cheyenne R. Butcher(Moores Cancer Center), Jonathan A. Pachter(Verastem (United States)), Sean Uryu(Pfizer (United States)), Florian J. Sulzmaier(National Foundation for Cancer Research), Elizabeth G. Kleinschmidt(Moores Cancer Center), Christine Lawson(University of California San Diego), Isabelle Tancioni(University of California San Diego)
Cited by 0
Related Papers
Differential regulation of cell motility and invasion by FAK
|The Journal of Cell Biology|2003|530
Fibronectin-Stimulated Signaling from a Focal Adhesion Kinase–c-Src Complex: Involvement of the Grb2, p130 <sup> <i>cas</i> </sup> , and Nck Adaptor Proteins
|Molecular and Cellular Biology|1997|432
VEGF-Induced Vascular Permeability Is Mediated by FAK
|Developmental Cell|2012|339
Adenovirus Endocytosis via α <sub>v</sub> Integrins Requires Phosphoinositide-3-OH Kinase
|Journal of Virology|1998|249